Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease.
<h4>Background</h4>Autoantibodies against pancreatic secretory-granule membrane glycoprotein 2 (GP2) have been demonstrated in patients with Crohn's disease but recently also with celiac disease (CD). Both entities are characterized by intestinal barrier impairment with increased gu...
Main Authors: | Martin W Laass, Nadja Röber, Ursula Range, Lydia Noß, Dirk Roggenbuck, Karsten Conrad |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0128104 |
Similar Items
-
Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease
by: Bogdanos Dimitrios P, et al.
Published: (2012-08-01) -
Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis.
by: Sandra George, et al.
Published: (2014-01-01) -
Adhesion of Salmonella to Pancreatic Secretory Granule Membrane Major Glycoprotein GP2 of Human and Porcine Origin Depends on FimH Sequence Variation
by: Rafał Kolenda, et al.
Published: (2018-08-01) -
Distal pancreatectomy and celiac axis resection for pancreatic body carcinoma involving celiac artery
by: Shih-Chun Chang, et al.
Published: (2017-01-01) -
Hepatobiliary Tract and Pancreatic Disorders in Celiac Disease
by: Hugh J Freeman
Published: (1997-01-01)